VRTX
Vertex Pharmaceuticals Incorporated
498.01
1 x 494.80
1 x 500.39
bid
ask
+
1.28
0.26%
1 @ 08:38 AM
501.95 +3.94 (0.79%)
| Ytd | 9.85% | |
| 1y | 8.97% |
495.00
day range
502.71
362.50
52 week range
507.92
| Open | 502.71 | Prev Close | 496.73 | Low | 495.00 | High | 502.71 | Mkt Cap | 126.40B |
| Vol | 1.20M | Avg Vol | 1.41M | EPS | 16.83 | P/E | 29.59 | Forward P/E | 23.19 |
| Beta | 0.31 | Short Ratio | 3.53 | Inst. Own | 97.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 445.09 | 200-d Avg | 443.20 | 1yr Est | 548.69 |
| Income Statement | |||
| Total Revenue | 2.99B | ||
| Revenues (USD) | 2.99B | ||
| Cost of Revenue | 392.80M | ||
| Gross Profit | 2.59B | ||
| Operating Expenses | 1.46B | ||
| Research and Development Expense | 961.60M | ||
| Selling, General and Administrative Expense | 493.70M | ||
| Operating Income | 1.14B | ||
| Income Tax Expense | 221.50M | ||
| Net Income | 1.03B | ||
| Net Income Common Stock | 1.03B | ||
| Net Income Common Stock (USD) | 1.03B | ||
| Consolidated Income | 1.03B | ||
| Earnings per Basic Share | 4.06 | ||
| Earnings per Basic Share (USD) | 4.06 | ||
| Earnings per Diluted Share | 4.02 | ||
| Earning Before Interest & Taxes (EBIT) | 1.25B | ||
| Earning Before Interest & Taxes (USD) | 1.25B | ||
| Weighted Average Shares | 254.10M | ||
| Weighted Average Shares Diluted | 256.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.49B | ||
| Cash and Equivalents (USD) | 5.49B | ||
| Investments | 7.50B | ||
| Investments Current | 1.75B | ||
| Investments Non-Current | 5.75B | ||
| Trade and Non-Trade Receivables | 2.00B | ||
| Current Assets | 11.73B | ||
| Property, Plant & Equipment Net | 3.29B | ||
| Total Assets | 26.48B | ||
| Total Debt | 1.99B | ||
| Current Liabilities | 3.88B | ||
| Debt Non-Current | 1.99B | ||
| Total Liabilities | 7.12B | ||
| Accumulated Retained Earnings (Deficit) | 14.59B | ||
| Accumulated Other Comprehensive Income | 24.80M | ||
| Shareholders Equity | 19.36B | ||
| Shareholders Equity (USD) | 19.36B | ||
| Assets Non-Current | 14.75B | ||
| Total Debt (USD) | 1.99B | ||
| Goodwill and Intangible Assets | 1.51B | ||
| Inventory | 1.77B | ||
| Liabilities Non-Current | 3.24B | ||
| Trade and Non-Trade Payables | 489.30M | ||
| Tax Assets | 2.95B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 55.90M | ||
| Net Cash Flow from Financing | -538.80M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 417.10M | ||
| Capital Expenditure | -133.40M | ||
| Issuance (Purchase) of Equity Shares | -538.40M | ||
| Net Cash Flow from Investing | -431.90M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -298.50M | ||
| Net Cash Flow from Operations | 1.43B | ||
| Effect of Exchange Rate Changes on Cash | -40.30M | ||
| Share Based Compensation | 166.40M | ||